Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DataMeds AI, Inc. - Common Stock (NQ:MEDS)

6.070 +4.450 (+274.69%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	188,430,891
Open	4.030
Bid (Size)	5.830 (100)
Ask (Size)	5.840 (100)
Prev. Close	1.620
Today's Range	4.000 - 12.31
52wk Range	0.8225 - 3.880
Shares Outstanding	40,630,815
Dividend Yield	49.42%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Small-Cap Stocks VEEA, ANY, MEDS, MYSZ Watch Now

September 15, 2026

Via AB Newswire

DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute

September 15, 2026

Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management

From DataMEDS AI, Inc.

Via ACCESS Newswire

Performance

YTD	+69.6%	+69.6%
1 Month	+307.4%	+307.4%
3 Month	+69.6%	+69.6%
6 Month	+69.6%	+69.6%
1 Year	+69.6%	+69.6%

More News

Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform

September 15, 2026

From Axe Compute Inc

Via GlobeNewswire

Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout

September 08, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI Provides Update on Corexa Health's Pharmacy Division

August 12, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

August 27, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

August 27, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

August 17, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record

August 14, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

August 10, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date

August 06, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"

August 05, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)

July 31, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands DataMEDS Licensing Agreement Into Commercial Healthcare

July 29, 2026

Via Investor Brand Network

Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI

July 29, 2026

From Datavault AI Inc.

Via Business Wire

DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

July 29, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders

July 27, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets

July 22, 2026

From DataMEDS AI, Inc.

Via ACCESS Newswire

TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.

September 20, 2024

Via Investor Brand Network

BioMedNewsBreaks — TRxADE Health Inc.’s (NASDAQ: MEDS) Subsidiary Expands Capabilities with Changes to Executive Leadership Team

August 05, 2024

Via Investor Brand Network

BioMedNewsBreaks — TRxAde Health Inc. (NASDAQ: MEDS), Scienture Inc. Announce All-Stock Business Combination Resulting in Combined Company

July 26, 2024

Via Investor Brand Network

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 22, 2024

Via Benzinga

Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 19, 2024

Via Benzinga

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend

July 09, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 04, 2024

Via Benzinga

Frequently Asked Questions

Is DataMeds AI, Inc. - Common Stock publicly traded?

Yes, DataMeds AI, Inc. - Common Stock is publicly traded.

What exchange does DataMeds AI, Inc. - Common Stock trade on?

DataMeds AI, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DataMeds AI, Inc. - Common Stock?

The ticker symbol for DataMeds AI, Inc. - Common Stock is MEDS on the Nasdaq Stock Market

What is the current price of DataMeds AI, Inc. - Common Stock?

The current price of DataMeds AI, Inc. - Common Stock is 6.070

When was DataMeds AI, Inc. - Common Stock last traded?

The last trade of DataMeds AI, Inc. - Common Stock was at 09/16/26 04:00 PM ET

What is the market capitalization of DataMeds AI, Inc. - Common Stock?

The market capitalization of DataMeds AI, Inc. - Common Stock is 246.63M

How many shares of DataMeds AI, Inc. - Common Stock are outstanding?

DataMeds AI, Inc. - Common Stock has 247M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.